A full beauty suite that offers professional-grade aesthetic procedures, Optimas is equipped with intense pulsed light, laser, and radio-frequency capabilities for skin remodeling, hair removal, and treatment of skin discoloration
Clinically proven to remodel subdermal and dermal tissue through fractional coagulation of fat and bulk sub-necrotic heating.
Three interchangeable fractional tips with different microneedle configurations:
12 pin Mopheus8 Prime for small narrow areas such as the periorbital zone and upper lip
24 pin Morpheus8 for larger facial areas such as the forehead, nasolabial folds, jawlines, and neck
24 pin Morpheus8 Resurfacing for the treatment of superficial conditions, including scarring
Safe on skin types up to and including VI with little risk of post inflammatory hyperpigmentation (PIH) which is common with other resurfacing methods.ds.
For facial soft tissue and small hard-to-reach treatment areas.
Delivers fractional resurfacing and subdermal treatments, penetrating tissue up to 5mm (4mm + 1mm thermal profile) to stimulate collagen production.
Morpheus8 is a safe and effective minimally invasive modular RF fractional solution for subdermal adipose remodeling.
-
Pre-Treatment Preparations
Advise the patient to avoid skin irritation or intentional skin tanning. Sun-screen is
advisable when outdoors during daylight hours.
The patient should discontinue any irritant topical agents for 2-3 days prior to treatment.
The patient should arrive for treatment with clean skin. There should be no lotion, make up, perfume, powder or bath/shower oil present on the skin in the area to be treated.
Immediately after treatment, most patients will experience erythema (redness) for 1-3
days, however for more aggressive treatments this may last longer. Slight to moderate
edema (swelling) and a mild to moderate sunburn sensation are also common post
treatment and may last 1-3 days. Skin may crust and peel for 2-7 days depending on
treatment settings.
Before discharge a topical ointment may be applied to the face, no bandages or wraps are
necessary.
There are no restrictions on bathing except to treat the skin gently, avoid scrubbing or
trauma to the treated area.
Avoid sun exposure to reduce the chance of hyperpigmentation.
The use of a zinc oxide sun block SPF 30+ at all times after 24-48 hours.
Multiple treatments over a period of several months may be required to achieve the
desired response. -
-
Contraindications
Pacemaker or internal defibrillator, or other metallic or electronic implant anywhere in
the body. The Hand piece should be used at least 1cm away from cochlear implants in the
ear.
Permanent implant in the treated area such as metal plates, screws and metal piercing or
silicon, unless deep enough in the periosteal plane.
Intra-dermal or superficial sub-dermal areas injected with Botox®/HA/collagen/fat
injections or other augmentation methods with bio-material, before the product has been
dissipated (up to 6 months), except Botox after binding to the facial muscles (3-7 days). It
is possible to treat sooner over injectable products placed in the deep, periosteal plane,
as soon as the area has healed (1-3 weeks).
Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
Pregnancy and nursing.
Severe concurrent conditions, such as cardiac disorders or sensory disturbances.
Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or
use of immunosuppressive medications.
Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in
the treatment area, may be treated only following a prophylactic regime.
Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and
hormonal virilization.
Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and
rash.
History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile
skin.
History of bleeding coagulopathies or use of anticoagulants in the last 10 days
Any facial surgery performed within a year prior to treatment.
Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last three
months, if face is treated.
Having received treatment with light, laser, RF, or other devices in the treated area within
2-3 weeks for non-ablative procedures, and 6-12 weeks for ablative fractional laser
resurfacing (according to treatment severity) prior to treatment, except special
recommendations.
Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents)
one week before and after each treatment session, as per the practitioner’s discretion. -
-
Possible Side Effects
Use of the system, whether it be proper or improper, could result in possible side effects.
Although these effects are rare and expected to be transient, any adverse reaction should be
immediately reported to the physician. Side effects may include any of those conditions listed
below. Side effects may appear either at the time of treatment or shortly after.
The side effects may include:
▪ Discomfort
▪ Excessive skin redness (erythema) and/or swelling (edema)
▪ Damage to natural skin texture (crust, blister, burn)
▪ Change of pigmentation (hyper- or hypo-pigmentation)
▪ Scarring
▪ Infection
Lumecca is a breakthrough intense pulsed light (IPL) that delivers up to 3X more energy in the 500-600 nm range to improve efficacy for vascular and pigmented lesions. It is optimized for clinicians to treat a variety of lesions with fewer sessions.
High efficiency of treatment due to high peak power and optimized output.
Complete photo rejuvenation in 1 or 2 treatments for most patients versus 4-6 treatments with standard IPL’s.
Reduces treatment time thanks to large spot size and high pulse repetition rate.
Strong sapphire cooling tip results in higher treatment comfort.
Pre-Treatment Preparations
Advise the patient to avoid skin irritation or intentional skin tanning. Sun-screen is advisable
when outdoors during daylight hours.
The patient should discontinue any irritant topical agents for 2-3 days prior to treatment.
The patient should not be freshly tanned or using sunless tanner.
The patient should be instructed to shave the area being treated prior to their
scheduled treatment.
The patient should arrive for treatment with clean skin. There should be no lotion, make-up,
perfume, powder or bath/shower oil present on the skin in the area to be treated.
A topical anesthetic should be used only as directed by a physician and only if necessary.
Areas of dental crowns, caps, braces, or other metal dental implants may be more sensitive to
treatment and the clinician may use dental rolls, gauze or a tongue depressor to isolate the
area and make the treatment more comfortable.
Post-Treatment Considerations
Sun block should be used for 3 weeks following the treatment.
Moisturizer may be applied after each treatment.
Make-up may be applied immediately after the treatment.
Morpheus8 Body, with 3D Smart Frame and Burst technology, is a safe and effective minimally invasive modular RF fractional solution for subdermal adipose remodeling of larger body areas such as abdomens, buttocks, thighs, and backs.
Morpheus8 Body delivers the deepest fractional treatments available. Its large surface tip consists of a matrix of 40 thin gold-coated microneedles penetrating subdermal tissue up to 8mm (7mm + 1mm thermal profile).
Equipped with new 3D Smart Frame functionality, Morpheus8 Body deploys bipolar RF energy in a sequential radiating pattern, beginning with the inner circle of micropins and radiating outward. RF energy is automatically adjusted for the distance and number of microneedles in each ring. Sequential RF deployment produces 3D tissue block heating and procedures that deliver more energy in a deliberate and uniform treatment pattern.
Burst mode RF Vulcanization technology enables Morpheus8 Body to automatically disperse bipolar RF energy to multi-level treatment depths in a single cycle. The ability to target tissue sequentially at three levels, in millisecond intervals, allows for a significant reduction in treatment times, minimizes skin injury, increases treatment uniformity, and enables customized full body fractional procedures.
Safe on skin types up to and including VI with little risk of post inflammatory hyperpigmentation (PIH) which is common with other resurfacing methods.ds.
Pre-Treatment Preparations
Advise the patient to avoid skin irritation or intentional skin tanning. Sun-screen is
advisable when outdoors during daylight hours.
The patient should discontinue any irritant topical agents for 2-3 days prior to treatment.
The patient should arrive for treatment with clean skin. There should be no lotion, make up, perfume, powder or bath/shower oil present on the skin in the area to be treated.
1.9 Post-Treatment Care
Immediately after treatment, most patients will experience erythema (redness) for 1-3
days, however for more aggressive treatments this may last longer. Slight to moderate
edema (swelling) and a mild to moderate sunburn sensation are also common post
treatment and may last 1-3 days. Skin may crust and peel for 2-7 days depending on
treatment settings.
Before discharge a topical ointment may be applied to the face, no bandages or wraps are
necessary.
There are no restrictions on bathing except to treat the skin gently, avoid scrubbing or
trauma to the treated area.
Avoid sun exposure to reduce the chance of hyperpigmentation.
The use of a zinc oxide sun block SPF 30+ at all times after 24-48 hours.
Multiple treatments over a period of several months may be required to achieve the
desired response.
Contraindications
Pacemaker or internal defibrillator, or other metallic or electronic implant anywhere in
the body. The Hand piece should be used at least 1cm away from cochlear implants in the
ear.
Permanent implant in the treated area such as metal plates, screws and metal piercing or
silicon, unless deep enough in the periosteal plane.
Intra-dermal or superficial sub-dermal areas injected with Botox®/HA/collagen/fat
injections or other augmentation methods with bio-material, before the product has been
dissipated (up to 6 months), except Botox after binding to the facial muscles (3-7 days). It
is possible to treat sooner over injectable products placed in the deep, periosteal plane,
as soon as the area has healed (1-3 weeks).
Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
Pregnancy and nursing.
▪ Severe concurrent conditions, such as cardiac disorders or sensory disturbances.
Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or
use of immunosuppressive medications.
Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in
the treatment area, may be treated only following a prophylactic regime.
Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and
hormonal virilization.
Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and
rash.
History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile
skin.
History of bleeding coagulopathies or use of anticoagulants in the last 10 days
Any facial surgery performed within a year prior to treatment.
Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last three
months, if face is treated.
Having received treatment with light, laser, RF, or other devices in the treated area within
2-3 weeks for non-ablative procedures, and 6-12 weeks for ablative fractional laser
resurfacing (according to treatment severity) prior to treatment, except special
recommendations.
Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents)
one week before and after each treatment session, as per the practitioner’s discretion.
Possible Side Effects
Use of the system, whether it be proper or improper, could result in possible side effects.
Although these effects are rare and expected to be transient, any adverse reaction should be
immediately reported to the physician. Side effects may include any of those conditions listed
below. Side effects may appear either at the time of treatment or shortly after.
The side effects may include:
▪ Discomfort
▪ Excessive skin redness (erythema) and/or swelling (edema)
▪ Damage to natural skin texture (crust, blister, burn)
▪ Change of pigmentation (hyper- or hypo-pigmentation)
▪ Scarring
▪ Infection